Kytopen
PrivateLast Round
Series B
Apr 7, 2026
Total Funding Raised
$44.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kytopen is a biotechnology company that provides a cell engineering platform for producing healthy and functional cells quickly and efficiently.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kytopen Comparables
Compare Kytopen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellFE | 87% | |
| Portal Biotechnologies | 87% | |
| Celetrix | 84% | |
Kytopen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 7, 2026 | ||||
| Grant | Aug 13, 2024 | ||||
| Convertible Debt | Feb 14, 2024 | ||||
| Series A | Sep 28, 2021 | ||||
| Grant | Jun 16, 2021 | ||||
Grant | Jun 2, 2020 |
Kytopen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A, Series B, Seed |
| National Institute of Allergy and Infectious Diseases | Grant |
| The Engine | Series A, Series B, Pre Seed, Seed |
| Engine Ventures | Series A, Seed, Series B |
| MassVentures | Grant, Series A, Series B |
| Northpond Ventures | Series B, Series A |
| Alexandria Venture Investments | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Raised Series B round.
- Sep 9, 2025
Partnered with T-CURX and Fraunhofer IZI to engineer cell therapies.
Kytopen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kytopen's valuation, stock price, and market status.